AR122512A1 - Cápsulas blandas de liberación retardada - Google Patents
Cápsulas blandas de liberación retardadaInfo
- Publication number
- AR122512A1 AR122512A1 ARP210101507A ARP210101507A AR122512A1 AR 122512 A1 AR122512 A1 AR 122512A1 AR P210101507 A ARP210101507 A AR P210101507A AR P210101507 A ARP210101507 A AR P210101507A AR 122512 A1 AR122512 A1 AR 122512A1
- Authority
- AR
- Argentina
- Prior art keywords
- delayed release
- dependent
- shell composition
- release soft
- soft capsules
- Prior art date
Links
- 230000003111 delayed effect Effects 0.000 title abstract 6
- 239000007901 soft capsule Substances 0.000 title abstract 5
- 230000001419 dependent effect Effects 0.000 abstract 7
- 239000000463 material Substances 0.000 abstract 5
- 239000000203 mixture Substances 0.000 abstract 5
- 239000013543 active substance Substances 0.000 abstract 2
- 239000000945 filler Substances 0.000 abstract 2
- 108010010803 Gelatin Proteins 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 210000001072 colon Anatomy 0.000 abstract 1
- 230000000112 colonic effect Effects 0.000 abstract 1
- 239000008121 dextrose Substances 0.000 abstract 1
- 229920000159 gelatin Polymers 0.000 abstract 1
- 239000008273 gelatin Substances 0.000 abstract 1
- 235000019322 gelatine Nutrition 0.000 abstract 1
- 235000011852 gelatine desserts Nutrition 0.000 abstract 1
- 230000000977 initiatory effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 235000010987 pectin Nutrition 0.000 abstract 1
- 229920001277 pectin Polymers 0.000 abstract 1
- 239000001814 pectin Substances 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/294—Inorganic additives, e.g. silica
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/231—Pectin; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/275—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of animal origin, e.g. chitin
- A23L29/281—Proteins, e.g. gelatin or collagen
- A23L29/284—Gelatin; Collagen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
- A23L29/35—Degradation products of starch, e.g. hydrolysates, dextrins; Enzymatically modified starches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4833—Encapsulating processes; Filling of capsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/50—Polysaccharides, gums
- A23V2250/502—Gums
- A23V2250/5072—Pectine, pectinate
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/54—Proteins
- A23V2250/542—Animal Protein
- A23V2250/5432—Gelatine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/60—Sugars, e.g. mono-, di-, tri-, tetra-saccharides
- A23V2250/61—Glucose, Dextrose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dispersion Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- General Preparation And Processing Of Foods (AREA)
Abstract
Las cápsulas blandas de liberación retardada comprenden un material de relleno y una composición de cubierta dependiente del pH, caracterizada porque la naturaleza de liberación retardada de las cápsulas puede lograrse sin un recubrimiento dependiente del pH o sin añadir polímeros convencionales dependientes del pH. Las cápsulas blandas de liberación retardada descritas en el presente documento son particularmente adecuadas para iniciar la liberación del agente activo en un lugar objetivo del entorno del colon. Reivindicación 1: Una cápsula blanda de liberación retardada que comprende lo siguiente: (a) un material de relleno; y (b) una composición de cubierta dependiente del pH, caracterizada por que el material de relleno comprende por lo menos un principio activo farmacéutico, donde la composición de cubierta dependiente del pH comprende gelatina, pectina y dextrosa, y donde la composición de cubierta dependiente del pH se disuelve / desintegra / rompe en el entorno del colon. Reivindicación 28: Un proceso de preparación de una cápsula blanda de liberación retardada según cualquiera de las reivindicaciones 1 - 27, que comprende los siguientes pasos: (a) preparar un material de relleno que comprende un agente activo; y (b) encapsular el material de relleno con una composición de cubierta dependiente del pH.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202063033417P | 2020-06-02 | 2020-06-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR122512A1 true AR122512A1 (es) | 2022-09-14 |
Family
ID=78829903
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP210101507A AR122512A1 (es) | 2020-06-02 | 2021-06-02 | Cápsulas blandas de liberación retardada |
Country Status (13)
Country | Link |
---|---|
US (1) | US20230225980A1 (es) |
EP (1) | EP4156971A1 (es) |
JP (1) | JP2023532180A (es) |
KR (1) | KR20230018445A (es) |
CN (1) | CN116528694A (es) |
AR (1) | AR122512A1 (es) |
AU (1) | AU2021283118A1 (es) |
BR (1) | BR112022024391A2 (es) |
CA (1) | CA3185807A1 (es) |
IL (1) | IL298602A (es) |
MX (1) | MX2022015160A (es) |
TW (1) | TW202203899A (es) |
WO (1) | WO2021247518A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023158777A1 (en) * | 2022-02-18 | 2023-08-24 | R.P. Scherer Technologies, Llc | Modified release valproic acid softgel capsule |
US20230414523A1 (en) * | 2022-06-13 | 2023-12-28 | R.P. Scherer Technologies, Llc | Enteric bisacodyl softgel capsule |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9895332B2 (en) * | 2013-10-30 | 2018-02-20 | Patheon Softgels, Inc. | Enteric soft capsules comprising polyunsaturated fatty acids |
US9895333B2 (en) * | 2014-06-26 | 2018-02-20 | Patheon Softgels Inc. | Enhanced bioavailability of polyunsaturated fatty acids |
SG11201702752RA (en) * | 2014-10-06 | 2017-06-29 | Fuji Capsule Co Ltd | Method of Manufacturing Enteric Seamless Soft Capsule |
US20170119680A1 (en) * | 2015-10-30 | 2017-05-04 | R.P. Scherer Technologies, Llc | Extended release film-coated capsules |
US20220400724A1 (en) * | 2019-10-28 | 2022-12-22 | R.P. Scherer Technologies, Llc | Delayed release softgel capsules in higher ph environment |
-
2021
- 2021-06-01 CA CA3185807A patent/CA3185807A1/en active Pending
- 2021-06-01 KR KR1020227045815A patent/KR20230018445A/ko active Search and Examination
- 2021-06-01 BR BR112022024391A patent/BR112022024391A2/pt unknown
- 2021-06-01 EP EP21816891.2A patent/EP4156971A1/en active Pending
- 2021-06-01 US US17/928,955 patent/US20230225980A1/en active Pending
- 2021-06-01 AU AU2021283118A patent/AU2021283118A1/en active Pending
- 2021-06-01 MX MX2022015160A patent/MX2022015160A/es unknown
- 2021-06-01 IL IL298602A patent/IL298602A/en unknown
- 2021-06-01 JP JP2022574329A patent/JP2023532180A/ja active Pending
- 2021-06-01 WO PCT/US2021/035175 patent/WO2021247518A1/en active Application Filing
- 2021-06-01 CN CN202180058038.2A patent/CN116528694A/zh active Pending
- 2021-06-02 TW TW110120024A patent/TW202203899A/zh unknown
- 2021-06-02 AR ARP210101507A patent/AR122512A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
AU2021283118A1 (en) | 2023-01-05 |
JP2023532180A (ja) | 2023-07-27 |
BR112022024391A2 (pt) | 2022-12-27 |
TW202203899A (zh) | 2022-02-01 |
US20230225980A1 (en) | 2023-07-20 |
KR20230018445A (ko) | 2023-02-07 |
IL298602A (en) | 2023-01-01 |
EP4156971A1 (en) | 2023-04-05 |
CA3185807A1 (en) | 2021-12-02 |
WO2021247518A1 (en) | 2021-12-09 |
MX2022015160A (es) | 2023-01-16 |
CN116528694A (zh) | 2023-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR122512A1 (es) | Cápsulas blandas de liberación retardada | |
AR119075A1 (es) | Cápsulas blandas de liberación diferida | |
AR124044A1 (es) | Cápsulas blandas de liberación retardada | |
CA2585721C (en) | Non-gelatin soft capsule system | |
CY1121587T1 (el) | Καψα χορηγησης | |
AR124043A1 (es) | Cápsulas blandas de liberación retardada | |
CR20120400A (es) | Pastillas de gelatina blanda con nicotina | |
CO6290641A2 (es) | Preparacion de capsula que contiene los ingredientes farmaceuticamente activos liquidos y solidos, la cual presenta exelentes propiedades de los ingredientes farmaceuticamente activos | |
AR114434A1 (es) | Cápsulas de gelatina blanda entéricas | |
AR115269A1 (es) | Cápsulas de gelatina blanda entéricas | |
CO2023001954A2 (es) | Cápsulas blandas de gelatina que incorporan formas de dosificación de liberación inmediata y extendida y métodos de fabricación | |
CO2021015117A2 (es) | Composición de naproxeno en cápsula blanda miniatura | |
AR090888A1 (es) | Vehiculos de liberacion de composiciones pesticidas | |
UY38496A (es) | Aparato y proceso para el encapsulado secundario de inclusiones sólidas utilizando el proceso de matriz rotativa | |
MX2022003883A (es) | Formulaciones en capsulas de gel blando de origen no animal, metodos de preparacion y metodos de uso de las mismas. | |
AR087032A1 (es) | Composiciones de capsulas de gelatina y metodos para fabricarlas | |
CO2023005753A2 (es) | Cápsulas de gelatina blanda de liberación modificada | |
AR119414A1 (es) | Cápsula blanda de gelatina entérica de inhibidor de la bomba de protones | |
AR117681A1 (es) | Método para producir una formulación de un fármaco de liberación demorada | |
CL2019001555A1 (es) | Preparación farmacéutica y método para su fabricación. | |
AR128560A1 (es) | Cápsula blanda de ácido valproico de liberación modificada | |
AR118320A1 (es) | Estabilidad mejorada del ingrediente farmacéutico activo (api) en cápsulas blandas | |
AR113301A2 (es) | Cápsulas blandas masticables que contienen almidón no gelatinizado | |
JP2019502606A (ja) | デュタステリドを含む経口用軟質カプセル剤形用包装材 | |
MX2023005641A (es) | Forma de dosificacion en capsula de gelatina blanda de talazoparib. |